clinical efficacy of GUDUCHI TAILA AND DASHAPAKA GUDUCHI TAILA in eka kustha(psoriasis).

COMPARATIVE PHARMACEUTICO- CLINICAL STUDY OF GUDUCHI TAILA AND DASHAPAKA GUDUCHI TAILA IN THE MANAGEMENT OF EKA-KUSHTHA (PSORIASIS).

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/03/018060

Enrollment

Registered

2019-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

Intervention1: GUDUCHI TAILA: DOSE 6 ML BD WITH LUKE WARM WATER FOR LOCAL APPLICATION AS PER REQUIREMENT Control Intervention1: DASHPAKA GUDUCHI TAILA: DOSE 6 ML BD ORALLY WITH LUKE WARM WATER FOR LOC

Eligibility

Inclusion criteria

Inclusion criteria: Patients with all forms of Ekakushtha (Psoriasis) with classical signs & symptoms of Ekakushtha (Psoriasis)

Exclusion criteria

Exclusion criteria: Age below 18yrs & more than 60yrs. Pregnant women Uncontrolled Diabetes Mellitus Any other serious systemic illness like AIDS, Malignancy etc

Design outcomes

Primary

Measure	Time frame
IMPROVMENT IN SIGN AND SYMPTOMS OF EKA KUSTHA (PSORIASIS)Timepoint: IMPROVMENT WILL BE ASSESSED AFTER 1 MONTH	—

Secondary

Measure	Time frame
IMPROVMENT IN GENERAL HEALTH CONDITION OF PATIENTSTimepoint: AFTER 1 MONTH OF TREATMENT	—

Countries

India

Contacts

Public ContactJIGISHA PATEL

IPGT AND RA

patgiri124@gmail.com9426947438

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026